Alpha 2-macroglobulin (α2M), a plasma glycoprotein produced in the liver, inhibits a variety of proteinases and thus considered to play important homeostatic roles in the body. This broad inhibitory spectrum has been explained by the trapping theory by which a proteinase recognizes a region of 25-30 amino acid peptide in α2M called bait region and cleaves it, leading to the conformational change of α2M, and to the subsequent entrapment and inhibition of the proteinase.
Introduction
Alpha 2-macroglobulin (α2M) is a protein that is capable of inhibiting enzymatic activities of many different kinds of proteinases including those of thiol, serine, metallo and aspartic acid type enzymes either of endogenous or foreign origins. Human alpha 2-macroglobulin (hα2M) is one of the major plasma glycoproteins with four identical 180 kDa subunits. It is produced by cells of several types including hep- region and a thioester bond both located within the middle of each of the subunits, have been shown to play important roles for α2M to inhibit proteinases. The primary structure of the bait region is unique in that it is susceptible to virtually all common proteinases Chu and Pizzo 1994; see Figure 1 ).
It has been hypothesized that the bait region proteolysis by a target proteinase triggers the autocleavage of the thioester bond in each subunit, leading to the conformational change of the molecule and to the subsequent entrapment and inhibition of the target proteinase, and further to the exposure of a receptor binding site which has otherwise been hidden within the molecule (Barrett and Starkey, 1973) .
Experimental evidence that supports the trap hypothesis has been accumulated: In an electrophoregram, native hα2M (slow form) moves slower than the thioester-cleaved hα2M (fast form) (Barrett et al., 1979; Bjork et al., 1985) . The interaction of hα2M and a wide variety of proteinases have been successfully explained by the theory (Mortensen et al., 1981; Borth, 1992) . It was also shown that the protein-proteinase complex is internalized into receptor-bearing cells like hepatocytes and macrophages (Pastan et al., 1977; Willingham et al., 1979) .
Although a vast majority of foreign, as well as endogenous, proteinases are inhibited by hα2M, there are still some, which are not, or incompletely inhibited by the molecule: among them are proteinases produced by Porphyromonas gingivalis (Bedi and Williams, 1994) , Clostridium perfringens (Wolf et al., 1992) and Serratia liquefaciens (Wolf et al., 1991) . The lack of inhibitory activity toward these proteinases has been explained either by the fact that some of these proteinases, such as Clostridium collagenase with its molecular weight of more than 100 kDa, are too large to be encaged in α2M, or that they are incapable of cleaving the bait region peptide (Robert and Hall, 1983; Bjork, 1984; Sottrup-Jensen and Birkedal-Hansen, 1989) .
The study of the mechanism of proteinase inhibition, as outlined above, suggests the possibility that, by introducing an artificial peptide sequence in the bait region using genetic engineering and recombinant production technologies, we could further test the trapping theory, and in addition, obtain new artificial proteinase inhibitor molecules each with an altered inhibition spectrum of potential industrial and/or therapeutic usefulness.
To test the possibility, we paid special attention to Achromobacter lyticus lysyl endopeptidase (Sekiyama and Masaki, 1994) , since its molecular weight, ca. 20 kDa as a dimer molecule, is not too large to be encaged in α2M, while the bait region of hα2M does not have lysyl residues, a prerequisite for the enzymatic action of lysyl endopeptidase.
Here we report some of the characteristics of genetically engineered recombinant hα2Ms (rhα2Ms) with Lys substitution in its bait region. Detailed procedures of the genetic engineering and recombinant production of wild type and altered hα2Ms are described (Nakamichi et al., 1998) .
Materials and methods

Construction of production systems for rhα2Ms
The procedure for the construction of recombinant wild type-and mutant rhα2M production systems are described in details separately (Nakamichi et al., 1998) . Briefly, cultured HepG2 cells (ATCC CCL61) were used as the source of hα2M cDNA. From the poly (A) + RNA obtained from a culture of HepG2 cells, double strand cDNA (ds-cDNA) was synthesized, and it was cloned into λgt10 phage vector. Using 32 P-labeled 5 -and 3 -end fragment probes of hα2M cDNA, wild type cDNA clones were isolated.
We designed two mutant hα2Ms with modified peptide sequences of bait region (Fig. 1) . Thus, one, called hα2M/K692, was designed to contain Lys, in place of Arg at position 692, and the other, hα2M/K696, to contain Lys, again in place of Arg at position 696. We chose Arg for substitution with Lys, intending to minimize chemical and structural changes of the whole molecule due to this substitution.
Corresponding to each of the above peptide substitutions, a modified nucleotide sequence was designed, i.e., TTT for Arg 692 substituted by TCT for Lys, and TTT for Arg 696 by GCG for Lys, respectively ( Fig. 1) . cDNAs with these bait region substitutions were obtained, as integrated in the plasmid vector pUC19, using the technique of unique site elimination (U. S. E.) mutagenesis kit (Pharmacia Biotech, Tokyo, Japan). The prototype and the two engineered cDNAs were further cloned into the mammalian cell expression vector, pcDSRα-neo 11 (Noda et al., 1994) . The constructs were designated as pcDSRα -neo 11/hα2M, pcDSRα -neo 11/K692hα2M and pcDSRα -neo 11/K696hα2M, respectively for wild type rhα2M, rhα2M/K692 and rhα2M/ K696.
The expression vectors were introduced into Chinese hamster ovary (CHO) K1 cells (ATCC CCL61), selected for producer clones with G418. The recombinant CHO cells were grown in Eagle's MEM (GIBCO BRL, Maryland, USA) supplemented with non-essential amino acids and 10% fetal bovine serum (FBS, JRH Biosciences, Lenexa, Kansas, USA) following the method described previously (Nakamichi et al., 1997) . In this study only one cell clone for the recombinant production of each of the three proteins was used, which will be referred to as rCHO/hα2M, rCHO/hα2M/K692, and rCHO/hα2M/K696, respectively.
DNA sequencing
The prototype and the two engineered cDNAs were thoroughly sequenced, and were confirmed to fit the designed sequences. For the sequence analyses, template plasmids were purified by a published method (Hattori and Sakaki, 1986) . M13/M4 universal and M13/RV reversal sequencing primers were purchased (Takara Shuzo, Shiga, Japan). Other primers shown in the figure legends were synthesized using an automated DNA synthesizer (Perkin Elmer, Chiba, Japan). Sequencing was carried out using a 7-DEAZA sequencing kit (Takara Shuzo) or an automated DNA sequencer (Perkin Elmer).
Production and purification of hα2Ms
For the production of wild-type and mutant hα2M proteins, the recombinant cells were transferred to roller bottles each with 1750 cm 2 surface area, and grown in a serum-free medium CHO-SFM-2 (GIBCO) for two days before harvesting spent culture medium. In some experiments a proteinase inhibitor Pefabloc SC (Merck, Darmstadt, Germany) and Leupeptin (Sigma, St. Louis, Missouri, USA) was added to the serumfree medium at the concentration of 0.05 mM and 1 µg/ml, respectively, in order to avoid non-specific proteolytic decay of the product during cultivation and downstream procedures.
For the purification of rhα2Ms, spent culture medium was treated with hydrochloric acid to adjust its pH to 6.0, and passed through a Chelating Sepharose Fast Flow column saturated with zinc ion (Pharmacia Biotech). Bound hα2M was eluted with an elution buffer (0.1 M acetate buffer containing 0.15 M NaCl pH 5.0).
Eluate was concentrated by reducing its volume and the elution buffer was replaced with PBS buffer. Spent medium collected from the culture of rCHO/K692 and rCHO/K696 cell lines was treated with hydrochloric acid to adjust its pH to 6.0 and passed through the Chelating Sepharose Fast Flow column saturated with zinc ion (Pharmacia Biotech). Bound hα2M was eluted with the same elution buffer as above. Eluate was concentrated by reducing its volume and the elution buffer was replaced by PBS buffer (Dangott and Cunningham, 1982) . Human plasma α2M was purified by the published method (Kan et al., 1985) .
Methylamine treatment and electrophoresis
Obligatory conformational change from the slow form to the fast form was induced by the treatment of hα2M with 200 mM methylamine (Tokyo Kasei, Tokyo) by overnight treatment in a Tris-HCl buffered solution (pH 8.0), essentially following the method of Barret et al. (1979) . To detect the slow form and the fast form, electrophoresis was performed using Phast Gel Gradient 4-15 on a Phast System (Pharmacia Biotech).
Enzyme inhibition assay
Inhibition of proteinase with hα2M was assayed according to Arakawa et al. (1989) except that the incubation buffer was changed to 0.145 M sodium chloride at 8 mM sodium phosphate, 1.4 mM potassium phosphate, 2.7 mM potassium chloride, pH 7.4. Various amounts of hα2M were incubated with or without 0.4 mg of trypsin (swine, and Type III, bovine pancreas; Sigma, St. Louis, Missouri, USA), or 0.7 mg of lysyl endopeptidase (Achromobactor lyticus M-497-1, Wako, Japan) in 250 ml of the above incubation buffer. The reaction mixture was first incubated for 10 min. at 37 • C, and then 2 ml suspension of 1.0% hide powder azure (Sigma) as chromogenic substrate for proteinases was added and incubated for further 30 min. at 37 • C. The supernatant was collected by centrifugation after the incubation period and absorbancy at 595 nm was measured. In some experiments, TLCK (Na-p-tosyl-l-lysine chloromethyl ketone, Sigma) was used to inhibit lysyl endopeptidase.
Results
Sequence analyses of cDNAs
The DNA sequence in the range around 692 to 696 was determined for each of the hα2M cDNAs of the wild-type, K692 and K696 as described in Materials and Methods, and the results shown in Figures 2 and 3. It was clearly shown that in K692, 5 AGA3 for Arg at codon 692 was substituted with 5 AAA3 for Lys, and in K696, 5 CGC3 for Arg with 5 AAA3 for Lys. Separately, we sequenced the wild-type hα2M cDNA, and confirmed that its entire sequence was identical to the previously reported sequence of hα2M cDNA of HepG2 origin in amino-acid codon level (Kan et al., 1985; Boel et al., 1990; Nakamichi et al., 1998) .
Interaction of hα2Ms with proteinases
Expression vectors, and recombinant CHO cells there of, were constructed using the wild type and mutant cDNAs, and preparations of hα2M proteins were obtained from the culture spent medium as described in Materials and Methods and in a separate paper (Nakamichi et al., 1998). The proteins were reacted with trypsin and lysyl endopeptidase. In Figure 4 , residual proteinase activity in the presence of the wild type rhα2M and rhα2M/K696 for trypsin and for lysyl endopeptidase are shown. Both rhα2Ms inhibited trypsin above the hα2M/proteinase ratio of 2. Rhα2M/K696 inhibited lysyl endopeptidase, but wild type rhα2M did not. For comparison, an inhibition profile of trypsin by plasma-derived natural hα2M is shown. We confirmed the inability of plasma-derived hα2M to inhibit lysyl endopeptidase in a separate experiment (Figure not shown) . Although rhα2M/K696 inhibited lysyl endopeptidase, the inhibitory efficacy was not as high as that for trypsin: It required a 5 to 10 times molar excess of the engineered protein over the proteinase (Fig. 4) . This low efficacy may be due to the instability of the proteinase/α2M complex in this case (see below).
Native hα2M and its genetically engineered derivatives reacted with lysyl endopeptidase differently from each other. For native hα2M which gives a 180 kDa band in SDS-PAGE (Fig. 5A lane 1 and Fig. 5B  lane 1) , a 90 kDa band always appeared in SDS-PAGE after a proteinase specific cleavage of bait region, as shown in Figure 5A (lane 4) and Figure 5B (lane 2) for trypsin-treated hα2M. For rhα2M/K696, a 90 kDa band was also noted after lysyl endopeptidase treatment, indicating that it is cleaved within its bait region (Figure not shown) . For rhα2M/K692, however, no distinct band appeared except for broad staining around 90 kDa together with numerous small bands indicating that rhα2M/K692 was degraded in the pres- ence of lysyl endopeptidase (Fig. 5B lanes 5 and 6) . Therefore it was not conclusive whether rhα2M/K692 was cleaved within its bait region or not.
Lysyl endopeptidase reacted with hα2M and genetically engineered derivative of the latter in regions other than the bait region. Lysyl endopeptidase-treated hα2M showed a distinct 150 kDa band in SDS-PAGE indicating that a peptide bond outside of its bait region was cleaved without resulting in the inhibition of the proteinase ( Fig. 5A lane 2, and Fig. 5B lane 3) . We noted a similar 150 kDa band in lysyl endopeptidasetreated rhα2M/K696 (Fig. not shown) indicating that this engineered molecule is cleaved both inside and outside of its bait region. As to rhα2M/K692, only a faint band at 150 kDa was seen in an early stage of lysyl endopeptidase treatment, probably because it was quickly degraded by the proteinase in a short period of time (Fig. 5B lanes 5 and 6) .
We confirmed that the transition from the slow form to the fast form, as triggered either by the methylamine-cleavage of thioester bond or by the trypsin-cleavage of bait region peptide, happens in the genetically engineered derivatives as well as in the native hα2M. Thus, trypsin-treated rhα2M/K692 showed the fast form in PAGE under a reducing condition ( Fig. 5C lane 2 in comparison with Fig. 5C lane 1 for untreated rhα2M/k692), as well as trypsintreated hα2M as shown separately (Nakamichi et al., 1998) . A similar transition was also noted for rhα2M/K692 after methylamine treatment (Nakamichi et al., 1998) . A fast form band was also noted for rhα2M/K696 after treatment either with methylamine or with lysyl endopeptidase (Figure not shown) . The change from the slow form to the fast form, however, was not clearly shown for lysyl endopeptidase-treated rhα2M/K692 (Fig. 5C lanes 3-6) . These results indicate that the thioester-bond-mediated machinery for conformational change is maintained in both of the genetically engineered hα2Ms, and suggest that, although Lys at 692 is located within the bait region, it is not easily accessible to lysyl endopeptidase.
Discussion
In the present study using recombinant mutant α2Ms, we provided additional evidence supporting the trapping theory: We presented that, by introducing a peptide sequence susceptible to a proteinase into the bait region of α2M, a recombinant α2M protein capable of inhibiting the proteinase, which is otherwise not inhibited, was obtained. To our knowledge, this is the first experiment to show this, and also to extend the value of engineered α2M-derived proteinases of potential industrial and/or therapeutic usefulness.
It should be noted, however, that the new inhibitory function was confirmed only for one of the two engineered α2Ms, i.e., rhα2M/K696, and even in that case the inhibitory efficiency was not as high as we expected: rhα2M/K696 required a 5 to 10 times molar excess of the protein over lysyl endopeptidase. We noted that when rhα2M/K696 was reacted with lysyl endopeptidase, enzymatic degradation of the protein proceeded further, than in the case of wild type (data not shown). This is in contrast to the case where hα2M is complexed with trypsin or chymotrypsin: hα2M becomes resistant against further attack of proteinases including that of lysyl endopeptidase. We speculate either that the structural transition of hα2M after the bait region cleavage due to lysyl endopeptidase is not quite as complete as in the case of other proteinases, or that the trapped proteinase continues to degrade hα2M from inside of the latter. We think the latter possibility more likely because there has been an observation that trapped enzymes would later be freed from α2M as an active molecule (Borth and Teodorescu, 1986; Molla et al., 1987) .
Although rhα2M/K692 contains Lys in its bait region, it was not split at the bait region by lysyl endopeptidase as detected by 90 kDa fragment. Instead, a treatment with the proteinase yielded a 150 kDa fragment, showing that rhα2M/K692 was cleaved at a site different from its bait region. It may be relevant to mention here that, proteinase cleavage sites are frequently located between 681 to 687 and 696 and 700, but scarcely between 688 to 695 . The results may suggest that within the bait region some peptide bonds are inaccessible to a proteinase.
Inhibition of lysyl endopeptidase has clearly not been in the program of hα2M evolution. Molecular engineering of α2M, as extension of this study will not only further practical aspects of technological utilization of recombinant proteins, but also evolutional aspects of this interesting protein.
